Tay-Sachs disease: Part 1. the risk to non-Jews
Hecht, F.; Wagner, R.C.; Powers, R.J.
Arizona Medicine 41(9): 597-599
1984
ISSN/ISBN: 0004-1556 PMID: 6497685 Document Number: 239220
Document emailed within 1 workday
Related Documents
Brillante, R.; Yang, V.; Proos, A.; Burnett, L. 1995: PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews Clinical Chemistry 41(2): 321-322Tamasu, S.; Nishio, H.; Ayaki, H.; Lee, M.J.; Mizutori, M.; Takeshima, Y.; Nakamura, H.; Matsuo, M.; Maruo, T.; Sumino, K. 1999: Prenatal diagnosis of a Japanese family at risk for Tay-Sachs disease. Application of a fluorescent competitive allele-specific polymerase chain reaction (PCR) method Kobe Journal of Medical Sciences 45(6): 259-270
Biran, N.; Jagannath, S.; Chari, A. 2013: Risk stratification in multiple myeloma, part 1: characterization of high-risk disease Clinical Advances in Hematology and Oncology: H&o 11(8): 489-503
Gelbart, M. 1998: Tay-Sachs disease Nursing Times 94(11): 39
Novoa, F.; Colombo, M.; Clericus, J. 1974: Tay-Sachs disease Revista Chilena de Pediatria 45(6): 495-499
McKusick, V.A. 1973: Ethnic distribution of disease in non-Jews Israel Journal of Medical Sciences 9(9): 1375-1382
Van Der Horst, R.L. 1973: Tay-Sachs disease in South Africa South African Medical Journal 47(5): 181-183
Nutman, J.; Navon, R.; Nitzan, M.; Gadoth, N. 1985: Tay-Sachs disease in an Arab child Israel Journal of Medical Sciences 21(1): 77-78
O'Brien, J.S. 1973: Tay-Sachs disease: from enzyme to prevention Federation Proceedings 32(2): 191-199
Johnson, C.Ann.; Levey, A.S.; Coresh, J.; Levin, A.; Lau, J.; Eknoyan, G. 2004: Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors American family physician 70(5): 869-876
Delvin, E.E.; Scriver, C.R.; Pottier, A.; Clow, C.L.; Goldman, H. 1972: Tay-Sachs disease: prenatal detection and diagnosis L'Union Medicale du Canada 101(4): 683-688
Adachi, M.; Torii, J.; Schneck, L.; Volk, B.W. 1971: The fine structure of fetal Tay-Sachs disease Archives of Pathology 91(1): 48-54
Navon, R.; Argov, Z.; Brand, N.; Sandbank, U. 1981: Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype Neurology 31(11): 1397-1401
Rivin, B.E.; Slome, C. 1977: Screening programs for Tay-Sachs disease in North Carolina North Carolina Medical Journal 38(11): 649-651
Nassau, E. 1946: Symptoms of familial amaurotic idiocy (Tay-Sachs disease) Annales Paediatrici. International Review of Pediatrics 166: 265-268
Seligsohn, U.; Modan, M. 1981: Definition of the population at risk of bleeding due to factor Xi deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection Israel Journal of Medical Sciences 17(6): 413-415
Austein, C.F.; Seashore, M.R.; Mick, S.S. 1981: Knowledge and attitudes toward Tay-Sachs disease among a college student population Yale Journal of Biology and Medicine 54(5): 345-354
Padeh, B.; Shahar, S.; Navon, R.; Modan, M.; Goldman, B. 1977: Voluntary mass screening program for Tay-Sachs disease in Israel Harefuah 92(11): 481-485
Tsukahara, T.; Kadota, R.L. 1977: Economic considerations in genetic screening programs for Tay-Sachs disease Progress in Clinical and Biological Research 18: 319-327
Peleg, L.; Gazit, E.; Goldman, B.; Akstein, E. 1995: Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease Harefuah 129(11): 475-480